[HTML][HTML] CXCR4-targeted theranostics in oncology

AK Buck, SE Serfling, T Lindner, H Hänscheid… - European Journal of …, 2022 - Springer
A growing body of literature reports on the upregulation of CXC motif chemokine receptor 4
(CXCR4) in a variety of cancer entities, rendering this receptor as suitable target for …

[HTML][HTML] New PET radiotracers for the imaging of neuroendocrine neoplasms

E Fortunati, G Argalia, L Zanoni, S Fanti… - … Treatment Options in …, 2022 - Springer
Opinion statement Neuroendocrine neoplasms (NEN) are a heterogeneous group of
tumours derived from cells of neuroendocrine origin and can potentially arise everywhere in …

Imaging of CXC motif chemokine receptor 4 expression in 690 patients with solid or hematologic neoplasms using 68Ga-pentixafor PET

AK Buck, A Haug, N Dreher, A Lambertini… - Journal of Nuclear …, 2022 - Soc Nuclear Med
In recent years, molecular imaging addressing the CXC motif chemokine receptor 4
(CXCR4) has increasingly been used in various clinical settings. Here, we aimed to assess …

[HTML][HTML] Impact of CXCR4-directed PET/CT on staging and proposed oncologic management in patients with digestive system tumors

A Weich, SE Serfling, W Schlötelburg… - Clinical nuclear …, 2023 - journals.lww.com
Purpose To elucidate the influence of CXC motif chemokine receptor 4 (CXCR4)–directed
imaging on staging and proposed oncologic management in patients with digestive system …

Nuclear medicine application of pentixafor/pentixather targeting CXCR4 for imaging and therapy in related disease

Z Chen, Q Xue, S Yao - Mini Reviews in Medicinal Chemistry, 2023 - ingentaconnect.com
CXC-motif chemokine receptor 4 (CXCR4) is a novel predictive biomarker for metastasis
and poor prognosis in individuals with malignancies. CXCL12 is the only cognate ligand of …

[HTML][HTML] CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology

N Dreher, S Hahner, CT Fuß, W Schlötelburg… - European Journal of …, 2024 - Springer
Background CXC motif chemokine receptor 4 (CXCR4) is overexpressed in various solid
cancers and can be targeted by CXCR4-directed molecular imaging. We aimed to …

Molecular imaging theranostics of neuroendocrine tumors

E Fortunati, N Bonazzi, L Zanoni, S Fanti… - Seminars in Nuclear …, 2023 - Elsevier
Neuroendocrine neoplasms (NEN) are rare and heterogeneous tumors, originating mostly
from the gastro-entero-pancreatic (GEP) tract followed by the lungs. Multidisciplinary …

Chemokine receptor PET imaging: Bridging molecular insights with clinical applications

C Hunter, B Larimer - Nuclear Medicine and Biology, 2024 - Elsevier
Chemokine receptors are important components of cellular signaling and play a critical role
in directing leukocytes during inflammatory reactions. Their importance extends to numerous …

[HTML][HTML] Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT

SE Serfling, C Lapa, N Dreher, PE Hartrampf… - Molecular Imaging and …, 2022 - Springer
Background CXCR4-directed positron emission tomography/computed tomography
(PET/CT) has been used as a diagnostic tool in patients with solid tumors. We aimed to …

[HTML][HTML] Nanobiotechnology augmented cancer stem cell guided management of cancer: liquid-biopsy, imaging, and treatment

S Sun, Q Yang, D Jiang, Y Zhang - Journal of Nanobiotechnology, 2024 - Springer
Cancer stem cells (CSCs) represent both a key driving force and therapeutic target of
tumoral carcinogenesis, tumor evolution, progression, and recurrence. CSC-guided tumor …